Atovaquone

Product NDC
66993-062
11-digit product format
669930062
Labeler code
66993
Product ID
66993-062_58b0ae61-aff1-4cec-bf03-eba8b8569a71
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
atovaquone
Dosage form
SUSPENSION
Route
ORAL
Labeler
Prasco Laboratories
Application
NDA020500
Marketing category
NDA AUTHORIZED GENERIC
Marketing start
2014-03-20
Marketing end
2020-09-30
Substance
ATOVAQUONE
Active strength
750 mg/5mL
Pharmacologic classes
Antimalarial [EPC],Antiprotozoal [EPC]
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct66993-062DDiscontinued by firm2026-07-31
excluded packagepackage66993-06266993-062-42DDiscontinued by firm2026-07-31
excluded packagepackage66993-06266993-062-72DDiscontinued by firm2026-07-31

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N020500-001MEPRONATOVAQUONE750MG/5MLSUSPENSION / ORALABRLD, RS1995-02-08

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
N020500-001AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-01 22:54:322026-06N020500-001MEPRON750MG/5MLSUSPENSION / ORALABRLD, RS1995-02-08a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-01 22:54:322026-06N020500-001AB1a50c72e98297…

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MEPRONATOVAQUONEGlaxoSmithKline LLCb426b6bf-f07e-4580-97ae-dfca1ddf5b8f2026-03-20Warnings, Adverse reactionsExact identifier
application applno (NDA): 020500
application number: NDA020500

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
66993-062-72ML - Milliliter66993-062b0b26c0c-1572-4d6f-9fcd-5a79c847551612014-04-03

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ATOVAQUONEACTIVE INGREDIENTY883P1Z2LTATOVAQUONE SUSPENSION [PRASCO LABORATORIES]3
ATOVAQUONEACTIVE MOIETYY883P1Z2LTATOVAQUONE SUSPENSION [PRASCO LABORATORIES]3
BENZYL ALCOHOLINACTIVE INGREDIENTLKG8494WBHATOVAQUONE SUSPENSION [PRASCO LABORATORIES]3
POLOXAMER 188INACTIVE INGREDIENTLQA7B6G8JGATOVAQUONE SUSPENSION [PRASCO LABORATORIES]3
SACCHARIN SODIUMINACTIVE INGREDIENTSB8ZUX40TYATOVAQUONE SUSPENSION [PRASCO LABORATORIES]3
WATERINACTIVE INGREDIENT059QF0KO0RATOVAQUONE SUSPENSION [PRASCO LABORATORIES]3
XANTHAN GUMINACTIVE INGREDIENTTTV12P4NEEATOVAQUONE SUSPENSION [PRASCO LABORATORIES]3